Paul Tudor Jones Guardant Health, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 397,875 shares of GH stock, worth $12.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

397,875

Previous 239,223 66.32%

Holding current value

$12.2 Million

Previous $6.91 Million 32.06%

% of portfolio

0.03%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $3.54 Million - $5.76 Million	158,652 Added 66.32%	397,875 $9.12 Million
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $3.84 Million - $7.62 Million	239,223 New	239,223 $6.91 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $1.16 Million - $1.58 Million	-53,607 Reduced 37.56%	89,130 $2.41 Million
Q3 2023 Nov 15, 2023	SELL	$25.8 - $39.97 $1.89 Million - $2.93 Million	-73,291 Reduced 33.93%	142,737 $4.23 Million
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $1.14 Million - $2.08 Million	-54,631 Reduced 20.18%	216,028 $7.73 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $2.42 Million - $3.57 Million	105,767 Added 64.14%	270,659 $6.34 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $4.19 Million - $9.86 Million	164,892 New	164,892 $4.49 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $453,425 - $1.22 Million	15,733 New	15,733 $635,000
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $5.41 Million - $7.24 Million	-54,789 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $5.62 Million - $8.48 Million	51,179 Added 1417.7%	54,789 $6.8 Million
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $565,200 - $796,815	-4,449 Reduced 55.21%	3,610 $551,000
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $805,577 - $1.1 Million	8,059 New	8,059 $1.04 Million
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $908,499 - $1.26 Million	-11,311 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $684,202 - $1.1 Million	11,311 New	11,311 $918,000
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $195,848 - $279,069	-3,063 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $105,060 - $300,112	3,063 New	3,063 $235,000

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.12B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account